Youthful hormones

Lancet

Volumn 348, Issue SUPPL.2, 1996, Pages 6-

  Orlander, Philip R ^a   Nader, Shahla ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 9844250807     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(96)98016-2     Document Type: Article

References (5)

1. Amato G, Izzo G, La Montagna G, Bellastella A. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects. Clin Endocrinol (Oxf) 1996; 45: 27-32.
2. Copinschi G, Van Onderbergen A, L'Hermite-Baleriaux M, et al. Effects of a 7 day treatment with a novel orally active growth hormone secretogogue MK-677 on 24 hour GH profile, IGF-1 and adrenocortical function in normal young men. J Clin Endocrinol Metab 1996; 81: 2776-82.
3. Fazio S, Sabatini D, Capaldo B, et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996; 334: 809-14.
4. Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996; 273: 974-77.
5. Johnson OL, Cleland JL, Lee HJ, et al. A month-long effect from a single injection of microencapsulated human growth hormone. Nat Med 1996; 2: 795-99.